Company Announcements

IQE plc: Results of AGM

Source: RNS
RNS Number : 8120T
IQE PLC
25 June 2024
 

IQE plc

 

 

Cardiff, UK

25 June 2024

 

 

Results of Annual General Meeting

 

 

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, is pleased to announce that at its 2024 Annual General Meeting, held today in London, UK. Resolution 8 was withdrawn at the start of the meeting and all other resolutions were duly passed.

Total votes cast: 522,396,650

Resolution 1: Receipt of Directors' Report & Financial Statements

For: 522,894,486 (99.99%)

Against: 72,822 (0.01%)

Withheld: 13,140

Resolution 2: Approval of the Directors' Annual Report on Remuneration

For: 508,563,445 (97.26%)

Against: 14,353,825 (2.74%)

Withheld: 63,178

Resolution 3: To re-elect Phil Smith

For: 508,826,377 (97.30%)

Against: 14,144,809 (2.70%)

Withheld: 9,262

Resolution 4: To re-elect Americo Lemos

For: 508,819,940 (97.30%)

Against: 14,144,701 (2.70%)

Withheld: 15,807

Resolution 5: To elect Jutta Meier

For: 522,795,837 (99.97%)

Against: 156,075 (0.03%)

Withheld: 28,536

Resolution 6: To re-elect Ellen Carol Chesney

For: 508,827,184 (97.30%)

Against: 14,144,002 (2.70%)

Withheld: 9,262

Resolution 7: To re-elect Victoria Hull

For: 522,812,451 (99.97%)

Against: 158,735 (0.03%)

Withheld: 9,262

Resolution 8: Withdrawn

Resolution 9: To elect Bamdad Bastani

For: 508,692,017 (97.28%)

Against: 14,249,266 (2.72%)

Withheld: 39,165

Resolution 10:  To elect Maria Marced

For: 522,718,120 (99.96%)

Against: 223,163 (0.04%)

Withheld: 39,165

Resolution 11:  To re-elect Harmesh Suniara

For: 508,670,879 (97.27%)

Against: 14,274,488 (2.73%)

Withheld: 35,081

Resolution 12:  Reappointment of auditor

For: 522,586,057 (99.94%)

Against: 323,573 (0.06%)

Withheld: 70,818

Resolution 13:  Directors' authority to allot shares

For: 522,668,048 (99.94%)

Against: 299,432 (0.06%)

Withheld: 12,968

Resolution 14:  Disapplication of pre-emption rights

For: 514,222,322 (98.33%)

Against: 8,724,838 (1.67%)

Withheld: 33,288

Resolution 15:  Additional authority for disapplication of pre-emption rights

For: 508,461,431 (97.23%)

Against: 14,504,386 (2.77%)

Withheld: 14,631

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Jutta Meier

Amy Barlow

           

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Ben Cryer

Kate Bannatyne

Adam Telling

           

Deutsche Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

 

ABOUT IQE

http://iqep.com

 

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.


IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFAMBTMTTTBRI